• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尸体肾移植后播散性龟分枝杆菌感染:对头孢西丁反应良好。

Disseminated Mycobacterium chelonei infection following cadaveric renal transplantation: favorable response to cefoxitin.

作者信息

Mehta R, Oliver L D, Melillo D, Milliorn K, Flye W, Fish J

出版信息

Am J Kidney Dis. 1983 Sep;3(2):124-8. doi: 10.1016/s0272-6386(83)80028-6.

DOI:10.1016/s0272-6386(83)80028-6
PMID:6351599
Abstract

This article describes a case of disseminated Mycobacterium chelonei infection in a renal transplant recipient. This patient, who underwent thoracic duct drainage prior to cadaveric renal transplantation, developed M chelonei bacteremia and numerous subcutaneous nodules a few weeks after transplantation. The M chelonei initially responded to amikacin and tetracycline. Because of side effects and bacterial resistance, however, these drugs had to be discontinued. Subsequent treatment with cefoxitin led to reduction in size of subcutaneous nodules, but control of the infection was not achieved until an intravascular nidus of infection at the anastomotic site of an arteriovenous fistula was removed.

摘要

本文描述了一例肾移植受者播散性龟分枝杆菌感染的病例。该患者在尸体肾移植前接受了胸导管引流,移植后几周出现龟分枝杆菌菌血症和大量皮下结节。龟分枝杆菌最初对阿米卡星和四环素治疗有反应。然而,由于副作用和细菌耐药性,这些药物不得不停用。随后使用头孢西丁治疗使皮下结节尺寸缩小,但直到动静脉瘘吻合部位的血管内感染病灶被清除,感染才得到控制。

相似文献

1
Disseminated Mycobacterium chelonei infection following cadaveric renal transplantation: favorable response to cefoxitin.尸体肾移植后播散性龟分枝杆菌感染:对头孢西丁反应良好。
Am J Kidney Dis. 1983 Sep;3(2):124-8. doi: 10.1016/s0272-6386(83)80028-6.
2
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.基于体外药敏结果对偶然分枝杆菌和龟分枝杆菌所致非肺部感染的治疗。
J Infect Dis. 1985 Sep;152(3):500-14. doi: 10.1093/infdis/152.3.500.
3
Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.用阿米卡星和头孢西丁治疗龟分枝杆菌引起的播散性疾病。两种药物均无杀菌作用以及粒细胞在临床反应中的可能作用。
Arch Intern Med. 1984 Oct;144(10):2063-5. doi: 10.1001/archinte.144.10.2063.
4
Antimicrobial activity of ofloxacin and other agents against mycobacterial isolates from postoperative sternotomy wounds.氧氟沙星及其他药物对胸骨切开术后伤口分枝杆菌分离株的抗菌活性。
Clin Ther. 1989 Nov-Dec;11(6):775-85.
5
Disseminated Mycobacterium chelonei infection: response to sulfonamides.播散性龟分枝杆菌感染:对磺胺类药物的反应。
Am Rev Respir Dis. 1979 Jul;120(1):197-201. doi: 10.1164/arrd.1979.120.1.197.
6
Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.突变抗性作为偶然分枝杆菌和龟分枝杆菌对氨基糖苷类及抗菌药物获得性耐药的机制。证据基于质粒分析、突变频率和氨基糖苷类修饰酶检测。
Am Rev Respir Dis. 1985 Aug;132(2):409-16. doi: 10.1164/arrd.1985.132.2.409.
7
Iatrogenic disseminated mycobacterium chelonei infection.医源性播散性龟分枝杆菌感染
Tubercle. 1984 Mar;65(1):53-7. doi: 10.1016/0041-3879(84)90030-8.
8
Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.阿米卡星、红霉素和强力霉素对龟分枝杆菌和偶然分枝杆菌的活性。
Tubercle. 1978 Dec;59(4):277-80. doi: 10.1016/0041-3879(78)90005-3.
9
Renal infection with Mycobacterium chelonei.龟分枝杆菌引起的肾脏感染。
Aust N Z J Med. 1980 Feb;10(1):44-7. doi: 10.1111/j.1445-5994.1980.tb03417.x.
10
Mycobacterium chelonei infection of a corneal graft.角膜移植的龟分枝杆菌感染
Br J Ophthalmol. 1987 Sep;71(9):690-3. doi: 10.1136/bjo.71.9.690.

引用本文的文献

1
Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update.实体器官移植受者的非结核分枝杆菌感染:最新进展。
J Clin Tuberc Other Mycobact Dis. 2016 Apr 27;4:1-8. doi: 10.1016/j.jctube.2016.04.001. eCollection 2016 Aug.
2
Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.实体器官和造血干细胞移植受者中非结核分枝杆菌感染的最新进展。
Curr Infect Dis Rep. 2014 Sep;16(9):421. doi: 10.1007/s11908-014-0421-1.